The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice

<p>Abstract</p> <p>The Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study was the first trial to assess whether statins might be of clinical benefit in those with recently <it>unstable</it> coronary disease. MIRACL found that high-dose ato...

Full description

Bibliographic Details
Main Author: Aronow Herbert D
Format: Article
Language:English
Published: BMC 2002-01-01
Series:Current Controlled Trials in Cardiovascular Medicine
Subjects:
Online Access:http://www.biomedcentral.com/1468-6708/3/3